Clinical Trial Update: Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer [EARLY_Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating the combination of abemaciclib and letrozole in patients with endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• FEMARA (letrozole)
• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: Northwestern University | Conditions: Endometrial Endometrioid Adenocarcinoma | EARLY_Phase 1 | Status: COMPLETED